Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royal (Wuxi) Biological is a biotechnology company based in Wuxi, China, specializing in the development and production of high-quality biological reagents and providing contract research services. The company offers a wide range of products including recombinant proteins, antibodies, and ELISA kits, primarily serving the global life sciences research and diagnostic industries. In addition to its product catalog, Royal (Wuxi) Biological provides custom services such as protein expression, antibody development, and stable cell line construction. The company is recognized for its expertise in mammalian cell expression systems and its commitment to supporting drug discovery and basic biological research through reliable technical support and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Royal (Wuxi) Biological.